Square Pharmaceuticals has recommended a 130 percent cash dividend for the fiscal year 2025-26 (FY26), backed by higher sales and profits.
The company made the decision at a board meeting yesterday.
Its sales rose around 13 percent to Tk 8,606 crore in FY26, while profit increased 18 percent to Tk 2,770 crore.
The company paid cash dividends of 120 percent, 110 percent and 105 percent in the previous three financial years. Before that, it paid 100 percent and 60 percent dividends.
Square Pharmaceuticals, the country’s largest pharmaceutical company, began its journey in 1958 under the leadership of the late Samson H Chowdhury.
It now exports to more than 40 countries and aims to boost overseas sales by making better use of its existing facilities.
Shares of the blue-chip company have remained relatively stable over the years. Over the past year, its share price ranged from Tk 198 to Tk 236. Yesterday, it traded at Tk 218.